Today

Agents

Chat

Arena

Discover

More

App

Edwards Lifesciences target price raised to $112 from $101 by Leerink Partners

EW•2026-11-05

Leerink Partners raised its target price for Edwards Lifesciences to $112 from $101.

Related News

G

Gildan Activewear Q3 sales miss estimates on softer demand; cuts outlook

GIL•2026-11-05

FS KKR Capital Q3 net investment income per share rises

FSK•2026-11-05

Genesis Energy's Q3 net income falls on higher expenses

GEL•2026-11-05

NCR Voyix Q3 net income swings to $24 million; revenue drops 20% to $539 million

VYX•2026-11-05

Americold swings to Q3 2026 net income of $683.4 million

COLD•2026-11-05

Edwards Lifesciences target price raised to $112 from $101 by Leerink Partners - EW News | Rallies